GSK plc

LSE:GSK Stock Report

Market Cap: UK£52.5b

GSK Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

LSE:GSK Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
20 Mar 25BuyUK£8,118Wendy Mira BeckerIndividual536UK£15.15
20 Mar 25BuyUK£26,500Jonathan SymondsIndividual1,750UK£15.14
20 Dec 24BuyUK£19,726Jonathan SymondsIndividual1,500UK£13.15
20 Dec 24BuyUK£7,202Wendy Mira BeckerIndividual546UK£13.19
30 Oct 24BuyUK£99,646Jonathan SymondsIndividual7,150UK£13.94
20 Jun 24BuyUK£32,291Jonathan SymondsIndividual2,000UK£16.15
20 Jun 24BuyUK£7,196Wendy Mira BeckerIndividual446UK£16.14

Insider Trading Volume

Insider Buying: GSK insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of GSK?
Owner TypeNumber of SharesOwnership Percentage
Public Companies1,699,1330.0418%
Individual Insiders4,444,7020.109%
State or Government7,089,8290.174%
Private Companies51,933,6761.28%
Employee Share Scheme67,192,4761.65%
General Public375,822,6849.24%
Institutions3,557,081,65187.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 53.65% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.6%
Dodge & Cox
390,345,932UK£5.0b4.87%2.34%
8.84%
BlackRock, Inc.
359,258,737UK£4.6b-3.6%0.1%
4.82%
The Vanguard Group, Inc.
195,821,109UK£2.5b1.66%0.05%
2.63%
FMR LLC
106,719,175UK£1.4b-5.5%0.12%
2.35%
State Street Global Advisors, Inc.
95,555,880UK£1.2b3.99%0.06%
2.32%
UBS Asset Management AG
94,261,491UK£1.2b8.06%0.15%
1.88%
Legal & General Investment Management Limited
76,502,953UK£987.6m-0.9%0.3%
1.81%
Norges Bank Investment Management
73,443,519UK£948.1m-2.54%0.1%
1.67%
Wellington Management Group LLP
67,830,968UK£875.7m-17.6%0.2%
1.65%
GlaxoSmithKline Employee Trust
67,192,476UK£867.4m-7.47%no data
1.49%
Schroder Investment Management Limited
60,534,369UK£781.5m-8.7%0.66%
1.48%
Silchester International Investors LLP
60,263,863UK£778.0m22.7%3.98%
1.38%
Mondrian Investment Partners Limited
56,048,921UK£723.6m5.19%6.53%
1.28%
Strategic Advisers LLC
51,919,298UK£670.3m-0.35%0.34%
1.24%
PRIMECAP Management Company
50,523,320UK£652.2m70.1%0.72%
1.11%
Fisher Asset Management, LLC
45,257,219UK£584.3m10.1%0.34%
1.1%
GlaxoSmithKline plc, Shareview Client
44,643,758UK£576.3m-1.17%no data
1%
HSBC Global Asset Management (UK) Limited
40,739,290UK£525.9m-23.9%0.3%
0.88%
Independent Franchise Partners, LLP
35,897,366UK£463.4m65.7%3.51%
0.87%
Columbia Management Investment Advisers, LLC
35,563,124UK£459.1m6.95%0.14%
0.87%
BNY Asset Management
35,303,410UK£455.8m46.3%0.12%
0.87%
Hargreaves Lansdown Asset Management Ltd.
35,194,231UK£454.3m1.13%1.45%
0.85%
Aviva Investors Global Services Ltd.
34,676,919UK£447.7m-10.6%0.9%
0.84%
Causeway Capital Management LLC
33,975,359UK£438.6m12.2%2.25%
0.83%
Amundi Asset Management SAS
33,652,548UK£434.4m43.9%0.12%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/14 11:13
End of Day Share Price 2025/04/11 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

GSK plc is covered by 64 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kamla SinghAlphaValue
John EadeArgus Research Company
Odile RundquistBaader Helvea Equity Research